Clinical Trial Update: Conbercept in Choroidal Neovascularization Secondary to Uveitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating conbercept for choroidal neovascularization secondary to uveitis; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization
• Uveitis

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chongqing Medical University | Conditions: Choroidal Neovascularization, Uveitis | Phase 2 | Status: UNKNOWN